Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2020-06-24 AGM Information
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Result of General Meeting
AGM Information Classification · 99% confidence The document starts with an 'RNS Number' and is dated June 24, 2020. The core content announces the 'Result of General Meeting' where all resolutions were passed, and provides details about the admission of new ordinary shares to trading on AIM. This announcement relates directly to the outcome of a shareholder vote/meeting and subsequent capital structure update (share admission). The presence of the RNS header and the nature of the announcement (results of a general meeting) strongly suggest a regulatory filing related to corporate actions. While 'Result of General Meeting' could imply AGM-R, the document is an official regulatory announcement disseminated via RNS, detailing the outcome of voting and subsequent share admission. Since it explicitly announces the results of a general meeting, 'AGM-R' (AGM Information) is a strong candidate, but the format is a standard regulatory news service release. Given the content focuses on the *results* of the vote, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is highly relevant. However, the document is a formal regulatory news service release (RNS) announcing the outcome of a general meeting and subsequent share admission. Since the primary action announced is the result of the vote, DVA is the most specific fit for the core event. If DVA were not available, RNS would be the fallback. Since DVA is available and directly addresses the 'Result of General Meeting', I select DVA.
2020-06-24 English
Update on COVID-19 Test Development Partnership
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated June 24, 2020. It contains an 'Update on COVID-19 Rapid Antigen Test Development Partnership' and concludes with a standard disclaimer stating, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and explicit mention of RNS strongly indicate a general regulatory announcement released via the London Stock Exchange's news service. Since the content is a specific operational update (partnership progress) and not a formal financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or DIRS), the most appropriate classification is the general regulatory filing category.
2020-06-24 English
Result of AGM
AGM Information Classification · 99% confidence The document is an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the closing statement referencing RNS as the news service of the London Stock Exchange, approved by the FCA. The core content announces the 'Result of Annual General Meeting' where all resolutions were passed (except one). This directly relates to shareholder voting results following a general meeting. The most specific code for official results from shareholder votes at any general meeting is DVA (Declaration of Voting Results & Voting Rights Announcements). Although it is distributed via RNS, the specific content points strongly to DVA. Since the document is short and reports the outcome of the AGM, DVA is the most accurate classification for the event being reported.
2020-06-22 English
Update on Affimer® Therapy for COVID-19 Infection
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 2969Q' and is dated '18 June 2020'. It contains an 'Update on Affimer® Therapy for COVID-19 Infection' and concludes with boilerplate text referencing RNS, the London Stock Exchange, and the Financial Conduct Authority (FCA). This structure is characteristic of a regulatory news service announcement, which serves as a general disclosure mechanism for listed companies. Since the content is a specific operational update (scientific progress) and not a formal financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or CAP), the most appropriate classification is the general regulatory filing category, RNS.
2020-06-18 English
Second Price Monitoring Extn
Regulatory Filings Classification · 95% confidence The document is very short (1374 characters) and contains the header "RNS Number : 2513Q". It discusses a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This type of brief, immediate market operational announcement, especially one explicitly referencing RNS (the news service of the London Stock Exchange) and dealing with trading mechanics rather than comprehensive financial results or formal reports, fits best under the general regulatory announcement category. Since there is no specific category for trading halts or price monitoring extensions, and it is a direct regulatory notification via RNS, the most appropriate classification is Regulatory Filings (RNS).
2020-06-17 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1357 characters) and contains an 'RNS Number' (2487Q) and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Price Monitoring Extension' related to trading activity, which is a specific, non-standard announcement. Since it is a brief regulatory notification distributed via the RNS system and does not fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or specific shareholder actions (DIV, DVA), it falls best under the general regulatory announcement category.
2020-06-17 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.